Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients

Inflammatory Bowel Diseases

Volumn 12, Issue 2, 2006, Pages 123-130

  Wells, Christopher W ^a,b   Lewis, Sarah ^a   Barton, J Roger ^a   Corbett, Sally ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Anemia; Cognitive function; Inflammatory bowel disease; Iron treatment; Quality of life

Indexed keywords

FERRIC HYDROXIDE SUCROSE; FERROUS SULFATE; HEMOGLOBIN; IRON;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE EXACERBATION; ENTERITIS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON THERAPY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; SAMPLE SIZE; SHORT FORM 36; ULCERATIVE COLITIS;

ANEMIA, IRON-DEFICIENCY; COGNITION; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC TESTS; HEMOGLOBINS; HUMANS; IRON COMPOUNDS; MALE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 33645030120     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000196646.64615.db     Document Type: Article

References (37)

1. Gasche C. Anaemia in IBD: the overlooked villain. Inflamm Bowel Dis. 2000;6:142-150.
2. MacDougall IC. Quality of life and anaemia: the nephrology experience. Semin Oncol. 1998;25:39-42.
3. Stivelman JC. Benefits of anaemia treatment on cognitive function. Nephrol Dial Transplant. 2000;15:29-35.
4. Gasche C, Dejaco C, Waldhoer T, et al. Intravenous iron and erythropoietin for anaemia associated with Crohn disease. Ann Intern Med. 1997;126:782-787.
5. Gasche C, Dejaco C, Reinisch W, et al. Sequential treatment of anaemia in UC with intravenous iron and erythropoietin. Digestion. 1999;60:262-267.
6. Gasche C, Waldhoer T, Feichtenschlager T, et al. Prediction of response to iron sucrose in IBD associated anaemia. Am J Gastroenterol. 2001;8:2382-2387.
7. Schreiber S, Howaldt S, Schnoor M, et al. Recombinant erythropoietin for the treatment of anaemia in inflammatory bowel disease. N Engl J Med. 1996;334:619-623.
8. Temple RM, Deary IJ, Winney RJ. Recombinant erythropoeietin improves cognitive function in patients maintained on chronic ambulatory peritoneal dialysis. Nephrol Dial Transplant. 1995;10:1733-1738.
9. Temple RM, Langan SJ, Deary IJ, et al. Recombinant erythropoietin improves cognitive function in chronic haemodialysis patients. Nephrol Dial Transplant. 1992;7:240-245.
10. Grimm G, Stockenhuber F, Schneeweiss B, et al. Improvement in brain function in haemodialysis patients treated with erythropoietin. Kidney Int. 1990;38:480-486.
11. Bruner AB, Joffe A, Duggan AK, et al. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet. 1996;348:992-996.
12. Verdon F, Burnand B, Fallab Stube CL, et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ. 2003;326:1124-1126.
13. MacDougall IC. Strategies for iron supplementation: oral versus intravenous. Kidney Int. 1999;55:S61-S66.
14. Fishbane S, Ungureanu VD, Maesaka JK, et al. The safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis. 1996;25:529-534.
15. Paull JM. A prospective study of dextran-induced anaphylactoid reactions in 5745 patients. Anaesth Intensive Care. 1987;15:163-164.
16. Hamstra RD, Block MH, Schocket AL. Intravenous iron dextran in clinical practice. JAMA. 1980;243:1726-1731.
17. Carrier J, Aghdassi E, Platt I, et al. Effect of oral iron supplementation on oxidative stress and colonie inflammation in rats with induced colitis. Aliment Pharmacol Ther. 2001;15:1989-1999.
18. Carrier J, Aghdassi E, Cullen J, et al. Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulphate sodium-induced colitis. J Nutr. 2002;132:3146-3150.
19. Aghdassi E, Carrier J, Cullen J, et al. Effect of iron supplementation on oxidative stress and intestinal inflammation in rats with acute colitis. Dig Dis Sci. 2001;46:1088-1094.
20. Millar AD, Rampton DS, Blake DR. Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis. Aliment Pharmacol Ther. 2000;14:1163-1168.
21. de Silva AD, Mylonaki M, Ramptom DS. Oral iron therapy in inflammatory bowel disease: usage, tolerance and efficacy. Inflamm Bowel Dis. 2003;31:316-320.
22. Faich G, Strobas J. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans. Am J Kidney Dis. 1999;33:464-470.
23. Oldenburg B, Koningsberger JC, Van Berge Henegouwen GP, et al. Iron and inflammatory bowel disease. Aliment Pharmacol Ther. 2000;15:429-438.
24. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96:804-810.
25. Han SW, McColl E, Steen N, et al. The inflammatory bowel disease questionnaire: a valid and reliable measure in ulcerative colitis patients in the North East of England. Scand J Gastroenterol. 1998;33:961-966.
26. Ware JE, Sherborne CD. The MOS 36-item short form health survey (SF36). Med Care. 1992;30:473-483.
27. Guyatt G, Feeney D, Patrick D. Issues in quality-of-life measurement in clinical trials. Control Clin Trials. 1991;12:81S-90S.
28. Patrick DL, Deyo RA. Generic and disease specific measures in assessing health status and quality of life. Med Care. 1989;27:S217-S232.
29. Fitzpatrick R, Davey C, Buxton MJ, et al. Evaluating patient-based outcomes measures for use in clinical trials. Health Technol Assess. 1998;2:1-74.
30. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National cooperative Crohn's disease study. Gastroenterology. 1976;70:439-444.
31. Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut. 1998;48:29-32.
32. The Rey auditory verbal learning test. In: Lezack MD, ed. Neuropsychological Assessment, 2nd ed. New York: Oxford University Press; 1983:422-429.
33. Gronwall DMA. Paced auditory serial addition task: a measure of recovery from concussion. Percept Motor Skills. 1977;44:367-373.
34. Dodrill CB. A neuropsychological battery for epilepsy. Epilepsia. 1978;19:611-623.
35. Nelson HE. The National Adult Reading Test (NART): Test Manual. Windsor, UK: NFER-Nelson; 1982.
36. Crawford JR. Estimation of premorbid intelligence: a review of recent developments. In: Crawford JR, Parker DM, eds. Developments in Clinical and Experimental Neuropsychology. New York: Plenum; 1989.
37. Silverstein AB. (1982) Two and Four Subtest Short Forms of the Wechsler Adult Intelligence Scale-Revised. J Consul Clin Psychol. 50:415-418.